Liquispex Liquid B2M Control Level 1 And 2
by Clinical Controls, Inc. 510(k)
Active
510(k) K946048
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK946048 | Date10 Feb 1995 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- Full name
- Liquispex(Tm) Liquid B2M Control Level 1 and 2
- 510(k) Number
- FDA Product Code
- JZG
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.5630
- Advisory Committee
- Immunology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
This device is a System, Test, Beta-2-Microglobulin Immunological test system. It is used for the in vitro quantitative measurement of beta-2-microglobulin in human serum.
It is supplied as a liquid control for use with the Liquispex test system. The device is classified as Class II under FDA regulation number 866.5630 and has received FDA 510(k) clearance K946048, determined to be substantially equivalent to a predicate device.
Other devices from Clinical Controls, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the LIQUISPEX(TM) Liquid B2M Control Level 1 and 2 used for?
It is used for the in vitro quantitative measurement of beta-2-microglobulin in human serum as a liquid control within the Liquispex test system, ensuring assay accuracy and reliability.
How is the LIQUISPEX(TM) Liquid B2M Control supplied and is it single-use?
It is supplied as a liquid control formulation designed for use with the Liquispex test system; while the data does not explicitly state single-use or reuse, as a liquid control for diagnostic testing, it is intended for single-use to prevent contamination and ensure consistent performance.
What regulatory clearance does the LIQUISPEX(TM) Liquid B2M Control have?
The device has received FDA 510(k) clearance under number K946048, determined to be substantially equivalent to a predicate device, and is classified as Class II under FDA regulation 866.5630.